Illumina, Inc.

ILMN

Illumina, Inc.
Current price$
5 days change-1.15%
Illumina (ILMN) to Report Q1 Earnings: What's in the Offing?

Illumina (ILMN) to Report Q1 Earnings: What's in the Offing?

Illumina (ILMN) is upbeat about its first-quarter sequencing consumable revenue growth.

Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19

Illumina Makes Software Toolkit Available Free of Charge to Support Worldwide Efforts to Combat COVID-19

Illumina, Inc. (NASDAQ: ILMN) announces the Illumina SARS-CoV-2 Data Toolkit, a new suite of data analysis tools and workflow functionality for resear

Earnings Preview: Illumina (ILMN) Q1 Earnings Expected to Decline

Earnings Preview: Illumina (ILMN) Q1 Earnings Expected to Decline

Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Illumina (ILMN) Posts Q1 Preliminary Results, Withdraws View

Illumina (ILMN) Posts Q1 Preliminary Results, Withdraws View

Investors remain optimistic on Illumina's (ILMN) strong preliminary revenue results for first-quarter 2020.

Illumina Reports Preliminary Revenue for First Quarter of Fiscal Year 2020

Illumina Reports Preliminary Revenue for First Quarter of Fiscal Year 2020

Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the first quarter of fiscal year 2020 and withdrew its 2020 guidance. Subject to

IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease Solutions

IDbyDNA and Illumina Partner to Deliver NGS Infectious Disease Solutions

IDbyDNA announces a global strategic partnership with Illumina to bring next-generation sequencing based workflows to the global microbiology market.

Why Is Illumina (ILMN) Down 12.2% Since Last Earnings Report?

Why Is Illumina (ILMN) Down 12.2% Since Last Earnings Report?

Illumina (ILMN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.

Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.

Illumina Files Additional Patent Infringement Suit Against BGI in the U. S.

Illumina earnings report beats estimated earnings per share by 7.06%, but misses revenue by 4.3%

Illumina earnings report beats estimated earnings per share by 7.06%, but misses revenue by 4.3%

Illumina reported earnings per share of $1. 7 on revenue of $907M, the consensus between analysts was $1.58 per share on revenue of $946M.

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2019. Fourth quarter 2019 results: Revenue

Can Sequencing Products Aid Illumina (ILMN) in Q4 Earnings?

Can Sequencing Products Aid Illumina (ILMN) in Q4 Earnings?

Illumina (ILMN) is upbeat about fourth-quarter and fiscal 2019 results after a strong third-quarter performance.

Illumina News: ILMN Stock 4% Lower on Weak 2020 Outlook

Illumina News: ILMN Stock 4% Lower on Weak 2020 Outlook

Illumina (ILMN) news for Monday includes ILMN stock falling on a weak outlook for 2020, as well as some other news about a deal.

ArcherDX and Illumina Partner for Future to Co-Market Portfolio of Planned In-Vitro Diagnostic (IVD) Tests

ArcherDX and Illumina Partner for Future to Co-Market Portfolio of Planned In-Vitro Diagnostic (IVD) Tests

/PRNewswire/ -- ArcherDX, Inc. today announced a non-exclusive, multi-year partnership with Illumina, Inc. (NASDAQ: ILMN) intended to broaden access of next. . .

Illumina Stock Could Illuminate This Healthcare ETF | ETF Trends

Illumina Stock Could Illuminate This Healthcare ETF | ETF Trends

Biotech firm Illumina, Inc. (NASDAQ: ILMN) scrapped a merger with Pacific Biosciences, but there's still a lot to like about Illumina

Illumina, Pacific Biosciences drop $1.2 billion merger agreement

Illumina, Pacific Biosciences drop $1.2 billion merger agreement

Illumina Inc. and Pacific Biosciences of California Inc. on Thursday said they have agreed to drop plans to merge. Under the merger agreement, announced Nov. . . .

Illumina Inks Deal With ArcherDX to Deliver NGS-Based IVD Kits

Illumina Inks Deal With ArcherDX to Deliver NGS-Based IVD Kits

Under the contract, ArcherDX will develop IVD tests that will run on Illumina's (ILMN) NextSeq 550Dx System.

Investors Should Wait for Sky-High Valuations on Illumina Stock to Deflate

Investors Should Wait for Sky-High Valuations on Illumina Stock to Deflate

You pay a high price for a company with near monopoly like Illumina. ILMN stock has 70% market share, but Its valuation is too high.

Why Illumina Stock Is Sinking Today | The Motley Fool

Why Illumina Stock Is Sinking Today | The Motley Fool

Questions about near-term prospects are weighing on the gene-sequencing stock.

Illumina earnings report beats estimated earnings per share by 27.46%, but misses revenue by 3.94%

Illumina earnings report beats estimated earnings per share by 27.46%, but misses revenue by 3.94%

Illumina reported earnings per share of $1. 93 on revenue of $838M, the consensus between analysts was $1.4 per share on revenue of $871M.

Loading ...